Qi Z, Zhou L, Dai S, Zhang P, Zhong H, Zhou W
Life Metab. 2025; 4(2):loaf002.
PMID: 40078933
PMC: 11897983.
DOI: 10.1093/lifemeta/loaf002.
Xu M, Zhou E, Shi H
Cells. 2025; 14(5).
PMID: 40072112
PMC: 11899299.
DOI: 10.3390/cells14050384.
Wang L, Xi M, Cao W, Qin H, Qin D, Chen S
Front Microbiol. 2025; 16:1517018.
PMID: 39973939
PMC: 11835812.
DOI: 10.3389/fmicb.2025.1517018.
Polyak H, Galla Z, Rajda C, Monostori P, Klivenyi P, Vecsei L
Int J Mol Sci. 2025; 26(3).
PMID: 39940744
PMC: 11817772.
DOI: 10.3390/ijms26030976.
Li G, Dong S, Liu C, Yang J, Rensen P, Wang Y
Life Metab. 2025; 4(2):loae039.
PMID: 39926388
PMC: 11803461.
DOI: 10.1093/lifemeta/loae039.
Lewy body diseases and the gut.
Sampson T, Tansey M, West A, Liddle R
Mol Neurodegener. 2025; 20(1):14.
PMID: 39885558
PMC: 11783828.
DOI: 10.1186/s13024-025-00804-5.
Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia? A systematic review and meta-analysis.
Hassib L, Kanashiro A, Pedrazzi J, Vercesi B, Higa S, Arruda I
Brain Behav Immun Health. 2025; 43():100923.
PMID: 39839986
PMC: 11745983.
DOI: 10.1016/j.bbih.2024.100923.
The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis.
He X, Hu M, Xu Y, Xia F, Tan Y, Wang Y
Nat Med. 2025; 31(2):627-638.
PMID: 39779925
DOI: 10.1038/s41591-024-03405-9.
A Small-Molecule Inhibitor of Gut Bacterial Urease Protects the Host from Liver Injury.
Richards-Corke K, Jiang Y, Yeliseyev V, Zhang Y, Franzosa E, Wang Z
ACS Chem Biol. 2025; 20(1):48-55.
PMID: 39778875
PMC: 11744669.
DOI: 10.1021/acschembio.3c00556.
Indole derivatives and their associated microbial genera are associated with the 1-year changes in cardiometabolic risk markers in Chinese adults.
Pan Y, Li Y, Peng Z, Zhang X, Ye S, Chen N
Nutr J. 2024; 23(1):160.
PMID: 39731110
PMC: 11681765.
DOI: 10.1186/s12937-024-01067-4.
Microbial Champions: The Influence of Gut Microbiota on Athletic Performance via the Gut-Brain Axis.
Xia W, Li X, Han R, Liu X
Open Access J Sports Med. 2024; 15:209-228.
PMID: 39691802
PMC: 11651067.
DOI: 10.2147/OAJSM.S485703.
The microbiota: a key regulator of health, productivity, and reproductive success in mammals.
Khan I, Nassar N, Chang H, Khan S, Cheng M, Wang Z
Front Microbiol. 2024; 15:1480811.
PMID: 39633815
PMC: 11616035.
DOI: 10.3389/fmicb.2024.1480811.
Influence of Tryptophan Metabolism on the Protective Effect of Weissella paramesenteroides WpK4 in a Murine Model of Chemotherapy-Induced Intestinal Mucositis.
Guimaraes G, Costa K, da Silva Santana Moura C, Moreira S, Marchiori J, de Menezes Santos A
Probiotics Antimicrob Proteins. 2024; .
PMID: 39602009
DOI: 10.1007/s12602-024-10413-1.
Diversity of Neurotransmitter-Producing Human Skin Commensals.
Rahmdel S, Purkayastha M, Nega M, Liberini E, Li N, Luqman A
Int J Mol Sci. 2024; 25(22).
PMID: 39596410
PMC: 11595044.
DOI: 10.3390/ijms252212345.
Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers.
Sun X, Shukla M, Wang W, Li S
NPJ Biofilms Microbiomes. 2024; 10(1):136.
PMID: 39587086
PMC: 11589602.
DOI: 10.1038/s41522-024-00610-9.
Effects of Phenolic Acids Produced from Food-Derived Flavonoids and Amino Acids by the Gut Microbiota on Health and Disease.
Kiriyama Y, Tokumaru H, Sadamoto H, Kobayashi S, Nochi H
Molecules. 2024; 29(21).
PMID: 39519743
PMC: 11548037.
DOI: 10.3390/molecules29215102.
The gut microbial metabolite indole-3-aldehyde alleviates impaired intestinal development by promoting intestinal stem cell expansion in weaned piglets.
Zhang J, Chen Y, Guo X, Li X, Zhang R, Wang M
J Anim Sci Biotechnol. 2024; 15(1):150.
PMID: 39511673
PMC: 11545576.
DOI: 10.1186/s40104-024-01111-7.
Gut microbiota and Parkinson's disease.
Wang L, Cui Y, Han B, Du Y, Salewala K, Wang S
Chin Med J (Engl). 2024; 138(3):289-297.
PMID: 39501822
PMC: 11771718.
DOI: 10.1097/CM9.0000000000003318.
Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease.
Merchak A, Bolen M, Tansey M, Menees K
Neurotherapeutics. 2024; 21(6):e00476.
PMID: 39482179
PMC: 11585893.
DOI: 10.1016/j.neurot.2024.e00476.
Sustainable production of the drug precursor tyramine by engineered Corynebacterium glutamicum.
Poethe S, Junker N, Meyer F, Wendisch V
Appl Microbiol Biotechnol. 2024; 108(1):499.
PMID: 39476177
PMC: 11525245.
DOI: 10.1007/s00253-024-13319-8.